Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT01011933 · COMPLETED

Trial details

NCT number: NCT01011933
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Recurrent Uterine Corpus Carcinoma

Start date: 2009-09-01
Primary completion: 2016-01-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.